M Vidgren

1.6k total citations
45 papers, 1.3k citations indexed

About

M Vidgren is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pharmaceutical Science. According to data from OpenAlex, M Vidgren has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 20 papers in Physiology and 11 papers in Pharmaceutical Science. Recurrent topics in M Vidgren's work include Inhalation and Respiratory Drug Delivery (34 papers), Asthma and respiratory diseases (20 papers) and Advanced Drug Delivery Systems (9 papers). M Vidgren is often cited by papers focused on Inhalation and Respiratory Drug Delivery (34 papers), Asthma and respiratory diseases (20 papers) and Advanced Drug Delivery Systems (9 papers). M Vidgren collaborates with scholars based in Finland, United Kingdom and United States. M Vidgren's co-authors include Petteri Paronen, Markku M. Nieminen, Panu Karjalainen, M Silvasti, Matti Koskinen, Väinö Turjanmaa, J. Nuutinen, J. Clifford Waldrep, Jarkko Ketolainen and Eero Suihko and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and CHEST Journal.

In The Last Decade

M Vidgren

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Vidgren Finland 23 787 488 346 165 134 45 1.3k
D Ganderton United Kingdom 22 793 1.0× 552 1.1× 281 0.8× 260 1.6× 109 0.8× 43 1.5k
Mary Lou Eskew United States 12 776 1.0× 381 0.8× 126 0.4× 273 1.7× 195 1.5× 25 1.4k
Francis Vanderbist Belgium 26 683 0.9× 423 0.9× 176 0.5× 195 1.2× 304 2.3× 48 1.5k
N. R. Labiris Canada 13 1.3k 1.6× 360 0.7× 354 1.0× 194 1.2× 171 1.3× 18 1.6k
Remigius U. Agu Canada 19 452 0.6× 773 1.6× 108 0.3× 127 0.8× 359 2.7× 60 1.6k
Cynthia Bosquillon United Kingdom 21 928 1.2× 496 1.0× 184 0.5× 303 1.8× 319 2.4× 41 1.6k
Maureen D. Donovan United States 23 274 0.3× 725 1.5× 83 0.2× 207 1.3× 409 3.1× 55 1.7k
Gabrielle Pilcer Belgium 16 1.1k 1.3× 574 1.2× 141 0.4× 436 2.6× 159 1.2× 21 1.4k
Norbert Verbeke Belgium 21 336 0.4× 643 1.3× 75 0.2× 74 0.4× 405 3.0× 34 1.5k
Michael Ikechukwu Ugwoke Belgium 13 384 0.5× 909 1.9× 56 0.2× 122 0.7× 337 2.5× 14 1.5k

Countries citing papers authored by M Vidgren

Since Specialization
Citations

This map shows the geographic impact of M Vidgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Vidgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Vidgren more than expected).

Fields of papers citing papers by M Vidgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Vidgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Vidgren. The network helps show where M Vidgren may publish in the future.

Co-authorship network of co-authors of M Vidgren

This figure shows the co-authorship network connecting the top 25 collaborators of M Vidgren. A scholar is included among the top collaborators of M Vidgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Vidgren. M Vidgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korhonen, Ossi, et al.. (2004). Evaluation of novel starch acetate–diltiazem controlled release tablets in healthy human volunteers. Journal of Controlled Release. 95(3). 515–520. 38 indexed citations
2.
Suihko, Eero, et al.. (2003). Starch acetate as a tablet matrix for sustained drug release. Journal of Controlled Release. 94(2-3). 293–302. 54 indexed citations
3.
Saari, Sina, M Vidgren, Väinö Turjanmaa, Matti Koskinen, & Markku M. Nieminen. (2003). No impairment of peripheral deposition in novel asthmatics treated with an MDI corticosteroid with spacer. Respiratory Medicine. 97(2). 152–158. 6 indexed citations
4.
Korhonen, Ossi, Soili Peltonen, Eero Suihko, et al.. (2002). Effects of physical properties for starch acetate powders on tableting. AAPS PharmSciTech. 3(4). 68–76. 42 indexed citations
5.
Newman, Stephen P., et al.. (2001). Comparison of Beclomethasone Dipropionate Delivery by Easyhaler ® Dry Powder Inhaler and pMDI Plus Large Volume Spacer. Journal of Aerosol Medicine. 14(2). 217–225. 24 indexed citations
6.
Kuikka, Jyrki T., et al.. (2000). Pulmonary deposition of lactose carriers used in inhalation powders. International Journal of Pharmaceutics. 196(1). 95–103. 50 indexed citations
7.
Korhonen, Ossi, Päivi Harjunen, Eero Suihko, et al.. (2000). Starch Acetates—Multifunctional Direct Compression Excipients. Pharmaceutical Research. 17(9). 1138–1143. 46 indexed citations
8.
Vidgren, M, et al.. (1999). Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. International Journal of Pharmaceutics. 181(1). 1–9. 82 indexed citations
9.
Nieminen, Markku M., J. Kokkarinen, Kari Liippo, et al.. (1998). A New Beclomethasone Dipropionate Multidose Powder Inhaler in the Treatment of Bronchial Asthma. Respiration. 65(4). 275–281. 12 indexed citations
10.
Saari, Sina, M Vidgren, Matti Koskinen, et al.. (1998). Regional Lung Deposition and Clearance of 99mTc-Labeled Beclomethasone-DLPC Liposomes in Mild and Severe Asthma. CHEST Journal. 113(6). 1573–1579. 63 indexed citations
11.
Vidgren, M, et al.. (1998). Nasal delivery systems and their effect on deposition and absorption. Advanced Drug Delivery Reviews. 29(1-2). 157–177. 191 indexed citations
12.
Vidgren, M, et al.. (1998). Pulmonary pharmacokinetics of cyclosporin A liposomes. International Journal of Pharmaceutics. 161(2). 205–214. 19 indexed citations
13.
Nieminen, Markku M., M Vidgren, Kari Laurikainen, et al.. (1994). Easyhaler<sup>®</sup> a Novel Multiple Dose Powder Inhaler: Clinically Equivalent to Salbutamol Metered Dose Inhaler and Easier to Use. Respiration. 61(1). 37–41. 25 indexed citations
14.
Vidgren, M, et al.. (1994). Pulmonary Deposition and Clinical Response of99mTc-Labelled Salbutamol Delivered from a Novel Multiple Dose Powder Inhaler. Pharmaceutical Research. 11(9). 1320–1324. 24 indexed citations
15.
Vidgren, M, et al.. (1990). Effect of the new spacer-device on the deposition of the inhaled metered dose aerosol.. PubMed. 45(12). 922–4. 3 indexed citations
16.
Karttunen, P, et al.. (1990). Pharmacokinetics of ibuprofen in man: a single-dose comparison of two over-the-counter, 200 mg preparations.. PubMed. 28(6). 251–5. 25 indexed citations
17.
Savolainen, Kaisa, et al.. (1988). Determination of Fat-Soluble Vitamins in a Pharmaceutical Dosage Form by Solid-Phase Extraction and Reversed-Phase Liquid Chromatography. Journal of Pharmaceutical Sciences. 77(9). 802–803. 21 indexed citations
18.
Vidgren, M, et al.. (1988). In Vitro and in Vivo Deposition of Drug Particles Inhaled from Pressurized Aerosol and Dry Powder Inhaler. Drug Development and Industrial Pharmacy. 14(15-17). 2649–2665. 17 indexed citations
19.
Vidgren, M, et al.. (1987). Effect of extension devices on the drug deposition from inhalation aerosols. International Journal of Pharmaceutics. 39(1-2). 107–112. 32 indexed citations
20.
Vidgren, M, et al.. (1987). Respiratory tract deposition of 99mTc-labelled drug particles administered via a dry powder inhaler. International Journal of Pharmaceutics. 39(1-2). 101–105. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Ganderton Breakdown of academic impact, for papers by Mary Lou Eskew Breakdown of academic impact, for papers by Francis Vanderbist Breakdown of academic impact, for papers by N. R. Labiris Breakdown of academic impact, for papers by Remigius U. Agu Breakdown of academic impact, for papers by Cynthia Bosquillon Breakdown of academic impact, for papers by Maureen D. Donovan Breakdown of academic impact, for papers by Gabrielle Pilcer Breakdown of academic impact, for papers by Norbert Verbeke Breakdown of academic impact, for papers by Michael Ikechukwu Ugwoke
Rankless by CCL
2026